Cooperated Commercial Products
| Number | Product | CAS | Indication | Qualification | |
|---|---|---|---|---|---|
| 1 | Ursodeoxycholic acid | 128-13-2 | Biliary Cirrhosis/Gallbladder Stones | WC / FDA (DMF # 039647) |
|
| 2 | Diosmin | 520-27-4 | Chronic Venous Insufficiency/Hemorrhoids | WC / DMF |
|
| 3 | Troxerutin | 7085-55-4 | Cardiovascular Diseases | WC / CEP / DMF |
|
| 4 | Rutin | 153-18-4 | Hemorrhage | WC / DMF |
|
| 5 | Nilotinib | 641571-10-0 | Ph+ CML | FDA (DMF # 039648) |
|
| 6 | Dasatinib | 302962-49-8 | Ph+ CML/Ph+ ALL | FDA (DMF # 039646) |
|
| 7 | Methotrexate | 59-05-2 | Neoplastic Diseases/Psoriasis/Rheumatoid Arthritis | FDA (DMF # 039758) |
|
| 8 | Irinotecan | 97682-44-5 | Advanced Colorectal Cancer | DMF |
|
| 9 | Letrozole | 112809-51-5 | Breast Cancer | DMF |
|
| 10 | Anastrozole | 120511-73-1 | Breast Cancer | DMF |
|
| 11 | Hesperidin | 520-26-3 | Cardiovascular Diseases | DMF |
|
| 12 | Ferric Carboxymaltose | 9007-72-1 | Iron Supplement | WC / DMF |
|
| 13 | Polysulfated Glycosaminoglycan | 64082-61-7 | Arthritis | DMF（2025 Q4） |
|
